BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22902549)

  • 1. HCV NS5A and IRF9 compete for CypA binding.
    Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
    J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
    Hopkins S; Bobardt M; Chatterji U; Garcia-Rivera JA; Lim P; Gallay PA
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3888-97. PubMed ID: 22585215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
    J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.
    Rengachari S; Groiss S; Devos JM; Caron E; Grandvaux N; Panne D
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E601-E609. PubMed ID: 29317535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
    Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
    J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
    Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
    Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.
    Grisé H; Frausto S; Logan T; Tang H
    J Virol; 2012 May; 86(9):4811-22. PubMed ID: 22345441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
    Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
    Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
    Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.
    Chatterji U; Bobardt MD; Lim P; Gallay PA
    J Gen Virol; 2010 May; 91(Pt 5):1189-93. PubMed ID: 20107018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
    Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
    Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
    J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
    Sung PS; Cheon H; Cho CH; Hong SH; Park DY; Seo HI; Park SH; Yoon SK; Stark GR; Shin EC
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10443-8. PubMed ID: 26216956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9.
    Zhang R; Fang L; Wang D; Cai K; Zhang H; Xie L; Li Y; Chen H; Xiao S
    Virology; 2015 Nov; 485():414-21. PubMed ID: 26342467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.
    Chatterji U; Bobardt M; Selvarajah S; Yang F; Tang H; Sakamoto N; Vuagniaux G; Parkinson T; Gallay P
    J Biol Chem; 2009 Jun; 284(25):16998-17005. PubMed ID: 19380579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.